Eli Lilly said in a social media post Friday its weight loss drug tirzepatide had received approval from Chinese regulators, further intensifying competition with
July 19, 2024
China's vaccine developers stuck with unused mRNA COVID shots and idle manufacturing plants are pursuing new targets for the novel messenger RNA
April 19, 2024
India's Biocon is searching for a partner in China to test generic versions of Novo Nordisk's hot-selling diabetes drug Ozempic and weight loss treatment Wegovy,
July 02, 2024A cancer cell therapy from CSPC Pharmaceutical Group that uses synthetic messenger RNA (mRNA) technology has received regulatory clearance in China for human
June 26, 2024Novo Nordisk's hugely popular weight-loss drug Wegovy has been approved in China, it said on Tuesday, the world's second-largest economy and the country estimated
June 25, 2024
A draft U.S. bill that has triggered a sell-off in shares of China's biotech firm Wuxi Apptec could deal a major blow not just to the firm but could also impact
April 26, 2024
Novo Nordisk is facing the prospect of intensifying competition in the promising Chinese market where drugmakers are developing at least 15 generic versions of its
June 24, 2024
Thermo Fisher Scientific has pledged to stop selling forensic technology and equipment in Tibet that could be used for identifying individuals, a spokesperson for
January 05, 2024
With more than a full year past since China eased restrictions and let COVID-19 sweep its households, scientists are worried a unique opportunity may be slipping
December 14, 2023
UK retail sales rise 1% in August
Beijing halts bubble tea offshore IPO approvals over soured Hong Kong listings, sources say
BOJ brings yen into sharper focus
European Commission president says she has arrived in Kyiv to discuss support for Ukraine
Column-Sterling feeds on peculiarly high BoE 'terminal rate': Mike Dolan
Rodgers sparkles in his first home start since his injury to lead Jets to 24-3 win over Patriots
Dodgers clinch 12th straight playoff berth on Shohei Ohtani's historic night
Diana Taurasi closes out what could be final home game of her 20-year career